Tharimmune, Inc. Relocates HQ, Reports Officer/Director Changes
Ticker: CNTN · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $100,000, $385,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, filing-update
TL;DR
Tharimmune moved its HQ to Red Bank, NJ, and made changes to its leadership team.
AI Summary
Tharimmune, Inc. announced on September 2, 2025, a change in its principal executive offices to 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ 07701. This filing also indicates updates regarding the election of directors, appointment of officers, and compensatory arrangements for certain officers.
Why It Matters
The relocation of principal executive offices may signal operational changes or growth for Tharimmune, Inc. Updates on officer and director appointments are crucial for understanding the company's leadership and governance.
Risk Assessment
Risk Level: low — This filing primarily concerns administrative changes like office relocation and standard corporate governance updates, with no immediate financial or operational risks apparent.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- September 2, 2025 (date) — Date of earliest event reported
- 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ 07701 (location) — New principal executive offices
- Delaware (location) — State of incorporation
- 001-41210 (company_id) — Commission File Number
FAQ
What is the new address for Tharimmune, Inc.'s principal executive offices?
The new address for Tharimmune, Inc.'s principal executive offices is 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ 07701.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 2, 2025.
In which state is Tharimmune, Inc. incorporated?
Tharimmune, Inc. is incorporated in Delaware.
What is Tharimmune, Inc.'s Commission File Number?
Tharimmune, Inc.'s Commission File Number is 001-41210.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, in addition to the change in principal executive offices.
Filing Stats: 470 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-09-08 16:15:47
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
- $100,000 — (the "Company") approved an increase of $100,000 in the base salary of each of Sireesh A
- $385,000 — e Executive Chairman of the Company, to $385,000. In addition, the Committee approved
Filing Documents
- form8-k.htm (8-K) — 34KB
- 0001493152-25-012808.txt ( ) — 197KB
- thar-20250902.xsd (EX-101.SCH) — 3KB
- thar-20250902_lab.xml (EX-101.LAB) — 33KB
- thar-20250902_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 8, 2025 Tharimmune, Inc. /s/ Sireesh Appajosyula Sireesh Appajosyula Chief Executive Officer -3-